ReviewFrontiers in immunology2026
Lymphocyte homing disorder: a concealed driver of intestinal immune collapse in sepsis.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. "Lymphocyte homing"-the targeted migration of lymphocytes between organs-serves as the physiological foundation for immune surveillance and local immune homeostasis. Under septic conditions, this precisely regulated process is severely disrupted, leading to failed recruitment of immune cells to infection/injury sites and exacerbated depletion of lymphoid tissues, ultimately inducing systemic immune imbalance. This review elaborates on three core aspects: the physiological basis of intestinal lymphocyte homing, the mechanisms by which sepsis disrupts this pathway (including immune microenvironment remodeling, abnormal homing signaling, and regulatory T cell dysfunction), and targeted interventional strategies (chemokine receptor antagonists, integrin-directed regulation, and microbiota-immune crosstalk modulation). Understanding lymphocyte homing disorder provides a novel breakthrough for deciphering septic immunosuppression and improving clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.